Summary
Airways disease is a frequent problem poorly recognised in older people. Many have reversible airway limitation and do not receive appropriate therapy. As in younger patients, pulmonary function tests are essential as a baseline and in relation to formal trials of treatment in both the diagnosis and management. Preferably, the assessment of all patients with airflow limitation should include a corticosteroid trial to correctly identify all patients who need long term prophylactic therapy. Many older patients have difficulty using the metered dose inhalers and the addition of volume spacer devices, though cumbersome, has many further advantages. In some patients, airflow limitation may be complicated by the presence of cardiac failure, arrhythmias and arterial hypoxia, and these problems also need to be reviewed.
Similar content being viewed by others
References
Al-Hillawi AH, Hayward R, Johnson NM. Incidence of cardiac arrhythmias in patients taking slow-release salbutamol and slowrelease terbutaline for asthma. British Medical Journal 288: 367, 1984
Ali NJ, Capewell S, Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46: 160–164, 1983
Allen SC, Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? British Journal of Diseases of the Chest 80: 45–49, 1986
Anthonisen NR, Wright EC, IPPB Trial Group. Bronchodilator response in chronic obstructive pulmonary disease. American Review of Respiratory Diseases 133: 814–819, 1986
Armitage JM, Williams SJ. Inhaler technique in the elderly. Age and Ageing 17: 275–278, 1988
Ashton K, Mead G, Dunsky M. Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and Cor pulmonale. American Review of Respiratory Diseases 127: 399–404, 1983
Banerjee DK, Lee GS, Malik SK, Daly S. Underdiagnosis of asthma in the elderly. British Journal Diseases of the Chest 81: 23–29, 1987
Barker DJP, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. British Medical Journal 303: 671–674, 1991
Barnes KL, Clifford R, Holgate ST, Murphy D, Comber P, et al. Bacterial contamination of home nebulisers. British Medical Journal 295: 812, 1987
Barnes PJ, Greening AP, Neville L, Timmers J, Poole GW. Single dose slow-release aminophylline at night prevents nocturnal asthma. Lancet 1: 299–301, 1982
Barnes P. Muscarinic receptor subtypes: implications for lung disease. Thorax 44: 161–167, 1989
Baudouin SV, Waterhouse JC, Tahtamouni T, Smith JA, Baxter J, Howard P. Long term domiciliary oxygen treatment for chronic respiratory failure reviewed. Thorax 45: 195–198, 1990
Beasley R, Cushley M, Holgate ST. A self management plan in the treatment of adult asthma. Thorax 44: 200–204, 1989
Branthwaite MA. Non-invasive and domiciliary ventilation: positive pressure techniques Thorax 46: 208–212, 1991
British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain Vol. 23, pp. 107–108, 1992
British Thoracic Society, Research Unit of the Royal College of Physicians, King’s Fund Centre, National Asthma Campaign. Guidelines for the Management of Asthma in adults. II Acute Severe Asthma. British Medical Journal 301: 797–799, 1990
Britton J, Hamley SP, Garrett V, Hadfield JW, Tattersfield AE. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax 43: 300–305, 1988
Brown PH, Blundell G, Greening AP, Crompton GK. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids. Thorax 45: 736–739, 1990
Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two, six and 12 minute walking tests in respiratory disease. British Medical Journal 284: 1607–1608, 1982
Capewell S, Reynolds S, Shuttleworth D, Edwards C, Finlay AY. Purpura and dermal thinning associated with high dose inhaled corticosteroids. British Medical Journal 300: 1548–1551, 1989
Coleman JJ, Vollmer WM, Barker AF, Schultz GE, Buist AS. Cardiac arrhythmias during combined use of beta adrenergic agonist drugs and theophylline. Chest 90: 45–51, 1986
Corris PA, Neville E, Nariman S, Gibson GJ. Dose response study of inhaled salbutamol powder in chronic airway obstruction. Thorax 38: 292–296, 1983
Crane J, Burgess C, Beasley R. Cardiovascular and hypokalemic effects of inhaled fenoterol, terbutaline and isoprenaline. Thorax 44: 136–140, 1989
Cusack B, Kelly JG, Lavan J, Nott J, O’Malley K. Theophylline kinetics in relation to age: the importance of smoking. British Journal of Clinical Pharmacology 10: 109–114, 1980
Cushley MJ, Lewis RA, Tattersfield AE. Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax 38: 908–913, 1983
Davies RJ, Hopkin JM. Nasal oxygen in exacerbations of ventilatory failure — under appreciated risk. British Medical Journal 299: 43–43, 1989
Diggory P, Bailey R, Vallon A. Effectiveness of inhaled bronchodilator delivery systems for elderly patients. Age and Ageing 20: 379–382, 1991
Dilworth JP, Higgs CMB, Jones PA, White RJ. Prescription of oxygen concentrators: adherence to published guidelines. Thorax 44: 576–578, 1989
Dow L, Coggon D, Osmond C, Holgate ST. A population survey of respiratory symptoms in the elderly. European Respiratory Journal 4: 267–272, 1991
Editorial. Long-term domiciliary oxygen therapy. Lancet 2: 365–367, 1985
Fairfax AJ, McNabb WR, Davies HJ, Spiro SG. Slow release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels. Thorax 35: 526–530, 1980
Farrer M, Francis AJ, Pearce SJ. Morning serum Cortisol concentration after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750ml spacing device. Thorax 45: 736–739, 1990
Fletcher C, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema, Oxford University Press, New York, 1976
Gerard WM, Light RW. Should the FVC be considered in evaluating response to bronchodilator? Chest 84: 87–89, 1983
Goldstein RS, Ramcharan V, Bowes G, McNicholas WT, Bradley D, et al. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. New England Journal of Medicine 310: 425–429, 1984
Grainger J, Atkinson M, Crane J, Burgess C, Culling C, et al. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977–1981. Thorax 45: 170–175, 1990
Grandordy BM, Thomas V, Lauture D, Demasac J. Cumulative dose-response curves for assessing salbutamol and ipratropium bromide in chronic asthma. European Respiratory Journal 1: 531–535, 1988
Guyatt GH, Townsend M, Pugsley SO, et al. Bronchodilator response in chronic airflow limitation. Effect on airway function, exercise capacity and quality of life. American Review of Respiratory Disease 135: 1069–1074, 1987
Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rates. Thorax 35: 732–738, 1980
Howarth PH, George CF. Adverse effects of bronchodilator drugs. Adverse Drug Reactions and Acute Poisoning Reviews 2: 25–49, 1983
Jones FL, Ekberg NL. Exacerbation of asthma by Timolol. New England Journal of Medicine 301: 270, 1979
Jones P. Quality of life measurement for patients with disease of the airways. Thorax 46: 676–682, 1991
Karim AKA, Thompson GM, Jacob TJC. Steroid aerosols and cataract formation. British Medical Journal 299: 918, 1989
Klein C, Hiatt WR, Gerber JG, Nies AS. Age does not alter human vascular and non-vascular beta-2-adrenergic responses. Clinical Pharmacology and Therapeutics 44: 573–578, 1988
Kuperman AS, Riker JB. The variable effect of smoking on pulmonary function. Chest 63: 655–660, 1973
Lane DJ. Chronic persistent asthma: nebulizers and therapy in additional to inhaled beta-2-agonists and steroids. Respiratory Medicine 85: 359–363, 1991
Laroche CM, Harries AVK, Newton RCF, Britton MG. Domiciliary nebulisers in asthma: a district survey. British Medical Journal 290: 1611–1613, 1985
Larson JL, Kim MJ, Sharp JT, Larson DA. Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease 138: 689–696, 1988
Lee HY, Stretton TB. Asthma in the elderly. British Medical Journal 4: 93–95, 1972
Leith DE, Bradley M. Ventilatory muscle training improves exercise capacity in chronic obstructive pulmonary disease patients. American Review of Respiratory Disease 121: 273–280, 1980
Levine JH, Michael JR, Quarnceri T. Multifocal atrial tachycardia — a toxic effect of theophylline. Lancet 1: 12–14, 1985
Lightbody IM, Ingram CG, Legge JS, Johnston RN. Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis. British Journal of Diseases of the Chest 72: 181–186, 1978
Lipworth BJ, Clark RA, Dhillon DP, Brown RA, McDevitt DG. β-Adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. British Journal of Clinical Pharmacology 26: 527–533, 1988
McKeon JL, Murree-Allen K, Saunders NA. Supplemental oxygen and quality of sleep in patients with chronic obstructive lung disease. Thorax 44: 184–188, 1989
Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1: 681–686, 1981
Milne JS, Williamson S. Respiratory symptoms in older people with age and sex differences. Respiration 29: 359–370, 1972
Morgan MDL, Singh BV, Frame MH, Williams SJ. Terbutaline aerosol given through the pear spacer in acute severe asthma. British Medical Journal 285: 849–850, 1982
Murphy D, Holgate ST. The use and misuse of domiciliary nebuliser therapy on the Isle of Wight. Respiratory Medicine 83: 349–352, 1989
Neville E, Corns PA, Vivian J, Narimen S, Gibson GJ. Nebulised salbutamol and angina. British Medical Journal 285: 796–797, 1982
Newman SP, Moren F, Pavia D, Little F, Clarke SW. Deposition of pressurised aerosols inhaled through extension devices. American Review of Respiratory Disease 124: 49–50, 1981
Nisar M, Walshaw M, Earis JE, Pearson MG, Calverley PMA. Assessment of reversibility of airways obstruction in patients with chronic obstructive airways disease. Thorax 45: 190–194, 1990
Nocturnal Oxygen Therapy Group. Continuous or nocturnal oxygen in hypoxaemic chronic obstructive lung disease: a clinical trial. Annals of Internal Medicine 93: 391–398, 1980
Olsen KR, Benowitz NL, Woo OF, Pond SM. Theophylline overdose: Acute single ingestion versus chronic overmedication. American Journal of Emergency Medicine 3: 386–394, 1985
Oral Bronchodilators. In British National Formulary, Vol. 21, pp. 99–107, British Medical Association, Pharmaceutical Press, 1991
Paterson IC, Crompton GK. Use of pressurised aerosols by asthmatic patients. British Medical Journal 1: 76–77, 1976
Pavia D, Lopezividriero MT, Agnew JE. Effect of four week treatment with oxitropium bromide on lung mucociliary clearance in patients with chronic bronchitis or asthma. Respiration 55: 33–43, 1989
Powell JR, Vozen S, Hopewell P, Costello J, Sheiler LB, et al. Theophylline disposition in acutely ill hospitalised patients the effects of smoking, heart failure, severe airways obstruction and pneumonia. American Review of Respiratory Disease 120: 229–238, 1971
Rees J. Beta-2-agonists and asthma. British Medical Journal 302: 1166–1167, 1991
Reid AR, Heap SW, King AR, Ibbertson HK. Two-year follow-up of bisphosphonate (APD) treatment in steroid osteoporosis. Lancet 2: 144–145, 1988
Reid DM. Corticosteroid induced osteoporosis and hormone implants. Lancet 1: 563, 1989
Ries AL, Ellis B, Hawkins RW. Upper extremity exercise training in chronic obstructive pulmonary disease. Chest 93: 688–692, 1988
Siegel D, Sheppard D, Gelb A, Weinberg PF. Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. American Review of Respiratory Disease 132: 283–286, 1985
Smith MJ, Hodson ME. Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax 38: 676–681, 1983
Smith R. Corticosteroids and osteoporosis. Thorax 45: 573–578, 1990
Snashall PD, Chung KF. Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. American Review of Respiratory Disease 144: 945–956, 1991
Stewart MF, Barclay J, Warburton R. Risk of giving intravenous aminophylline in acutely ill patients receiving maintenance treatment. British Medical Journal 288: 450, 1984
Tager IB, Segal MR, Speizer FE, Weiss ST. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. American Review of Respiratory Disease 138: 837–849, 1988
Taylor RG, Webb PA. Long term home nebuliser therapy. Thorax 43: 856, 1988
Tiep BL. Rehabilitation medicine Adding years to life. Reversing disability of Irreversible lung disease. Western Journal of Medicine 154: 591–597, 1991
Tiep BL, Burns M, Kao D, Madison R, Herreta J. Pursed lip breathing using ear oximetry. Chest 90: 218–221, 1986
Tweeddale PM, Alexander F, McHardy GJR. Short-term variability in FEVb1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 43: 487–490, 1987
Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium bromide and salbutamol in asthma. Thorax 36: 523–529, 1981
Ullman A, Hedner J, Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients: an evaluation of asthma symptoms and the possible development of tachyphylaxis. American Review of Respiratory Disease 142: 571–575, 1990
Van Schaycker CP, Folgering H, Harbers, Maas KL, van Weel C. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax 46: 355–359, 1991
Vestal RE, Wood AJJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly in the elderly. Clinical Pharmacology and Therapeutics 26: 182–186, 1979
Vyse T, Cochrane GM. Controlled release salbutamol tablets versus sustained release theophylline tablets in the control of reversible obstructive airways disease. Journal of International Medical Research 17: 93–98, 1989
Weir DC, Gove RI, Robertson AS, Burge PS. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 45: 112–117, 1990
Woodcock AA, Johnson MA, Geddes DM. Theophylline prescribing, serum levels and toxicity. Lancet 2: 610–613, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dow, L. The Epidemiology and Therapy of Airflow Limitation in the Elderly. Drug & Aging 2, 546–559 (1992). https://doi.org/10.2165/00002512-199202060-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199202060-00009